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Abstract
Objective: It has been shown that Mindbomb (Mib), an E3 Ubiquitin ligase, is an essential modulator of Notch signaling
during development. However, its effects on vascular development remain largely unknown.
Approaches and Results: We identified a number of novel proteins that physically interact with Mib, including the Factor
Inhibiting Hypoxia Inducible Factor 1 (FIH-1, also known as HIF1AN) from a yeast two hybrid screen, as previously reported.
In cultured cells, FIH-1 colocalizes with Mib1, corroborating their potential interaction. In zebrafish embryos, FIH-1 appears
to modulate VEGF-A signaling activity; depletion of fih-1 induces ectopic expression of vascular endothelial growth factor–a
(vegfa) and leads to exuberant ectopic sprouts from intersegmental vessels (ISVs). Conversely, over-expression of fih-1
substantially attenuates the formation of ISVs, which can be rescued by concurrent over-expression of vegfa, indicating that
FIH-1/HIF1AN may fine tune VEGF-A signaling.
Conclusions: Taken together, our data suggest that FIH-1 interacts with Mib E3 Ubiquitin ligase and modulates vascular
development by attenuating VEGF-A signaling activity.
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Introduction
During development, actively growing areas within embryos are
exposed to hypoxic environments, and the vascular network
undergoes a rapid expansion to accommodate an increasing
demand of oxygen and nutrient supplies. To facilitate formation of
blood vessels, cells experiencing hypoxia express Hypoxia Induc-
ible Factor 1a (HIF1a), a transcription factor which in turn
induces the expression of Vascular Endothelial Growth Factor-A
(VEGF-A) [1–3]. While VEGF-A serves as the main factor that
promotes proliferation, migration, and survival of endothelial cells
(ECs), additional factors are shown to provide an essential role
during vascular development [4,5]. For instance, Bone Morpho-
genetic Proteins provide context-dependent pro- and anti-angio-
genic effects [6,7] EphrinB2/EphB4 signaling regulates the
separation of arterial and venous ECs [8], and Angiopoietins
regulate maturation of blood vessels [9]. In addition, the Notch
pathway, which mediates lateral inhibition during development
[10], appears to be an essential factor to ensure proper vascular
development. Lack of Notch signaling causes failure of arterial
specification [11,12], ectopic tip cell formation which causes
excessive angiogenic sprouting [13], as well as negatively
modulating PFKFB3 expression to regulate metabolism of ECs
[14].
Mind bomb (Mib1) is an E3 Ubiquitin ligase whose function is
essential for Notch signaling [15]. Mib1 appears to be evolution-
arily conserved [16,17]and functionally related to Drosophila
Neuralized, which promotes endocytosis of Delta [15]. From a
large scale screen, mutations that affect the mind bomb (mib) locus
have been identified in zebrafish which cause pronounced
morphological defects in the anterior neural tube [15]. In addition,
ECs within developing intersegmental vessels (ISVs) of mib2/2
embryos generate exuberant secondary angiogenic sprouts
[12,18], suggesting that Mib1 may function as an anti-angiogenic
factor during development. Previous reports suggest that the
vascular defects of mib2/2 embryos appear to be dependent on
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Notch signaling; first, Mib1 has been implicated in the processing
of Delta, a key endogenous ligand for Notch [15]. Second,
inhibition of Notch signaling causes excessive angiogenic sprouts
within the ISVs, reminiscent of mib2/2 embryos [13]. However,
considering the promiscuity of E3 Ubiquitin ligases [19], it is likely
that additional targets and/or interactors of Mib1 may contribute
to the vascular phenotype in mib2/2 embryos. Moreover, the
vascular phenotype of mib2/2 embryos are more severe than those
with compromised Notch signaling [12,18], suggesting that there
may be additional factors that mediate Mib function during
vascular development.
In this report, we identified novel interactors of Mib using a
yeast two hybrid screen. Among potential interactors was Factor
Inhibiting Hypoxia Inducible Factor 1 (FIH-1, also known as
HIF1AN), which is an asparaginyl hydroxylase [20]. Previously,
FIH-1 has been shown to regulate HIF1a by forming a ternary
complex with an E3 Ubiquitin ligase, Von Hippel-Lindau tumor
suppressor (VHL) [20]. Moreover, Tseng and colleagues have
recently shown that FIH-1 forms a complex with Mib1 and Mib2
[21]. Inhibition of FIH-1 in zebrafish embryos substantially
increases ectopic angiogenic sprouts from the ISVs, while over-
expression of FIH-1 causes severe disruption in ISVs, suggesting
that FIH-1 functions as an anti-angiogenic factor during develop-
ment. Manipulation of VEGF-A can alleviate the vascular defects
caused by FIH-1 over-expression. Considering that FIH-1 targets
HIF1a, which induces the expression of VEGF-A [22,23], our
data suggest that FIH-1 may function as a mediator linking the
anti-angiogenic function of Mib to VEGF-A, and serve as an
essential modifier of signaling during vascular development.
Experimental Procedures
Zebrafish Maintenance
The animal study conducted here was performed under the
protocol approved by Yale University IACUC committee
(protocol # 2013–11402), and Chungnam University animal
research ethics committee. Wild type, Tg(kdrl:EGFP) s843 [24],
Tg(hsp:vegfaa165)ck4;Tg(kdrl:EGFP)s843 and mind bombta52b
mutant (mibta52b) [15] zebrafish were raised and kept under
standard laboratory conditions at 28.5uC. To better visualize
internal structures, embryos were incubated with 0.2 mM 1-
phenyl-2-thiourea (Sigma) to inhibit pigmentation and fixed at
specific developmental stages [25].
Yeast Two Hybrid Screening
A PCR fragment encoding the ankyrin repeats domain of Mib
was cloned into the vector pGBT9 (Clontech) downstream from
the GAL4 binding domain, pGBT9/Ank-MIB. After transforma-
tion of yeast host strain AH109 cells with pGBT9/Ank-MIB
plasmid, the yeast cells were sequentially mated with Y187 yeast
cells which were pre-transformed Human Matchmaker cDNA
Libraries (Clontech). Positive colonies were selected on Trp-, Leu-,
His-, and Ade-depleted plates, followed by a quantitative assay of
b-galactosidase activity. Plasmid DNAs were purified from the
candidate yeast colonies, and used as templates for PCR and
sequencing.
Preparation of DNA and mRNA for microinjection and
anti-sense RNA probes
To isolate zebrafish fih-1, RT-PCR was performed with total
RNA isolated from several stages of zebrafish embryos by using
specific primers. Used primer sequences were 59-AGAATT-
CAATGGCGGAGACCGACGGA-39 as forward primer and
59-ACTCGAGTTCAGTACAGGCTATTAACTCAG-39 as re-
verse primer for isolating of full length of fih-1. The amplified
fragment of the full-length zebrafish fih-1 cDNA was subcloned
into the pGEM-T easy vector and it was digested with EcoRI and
XhoI and was transferred into full-length fih-1 pCS2+ expression
vector. To make capped mRNA, plasmids were linearized by NotI
and transcribed with SP6 RNA polymerase using the mMES-
SAGE mMACHINE SP6 in vitro transcription kit (Ambion)
according to the manufacturer’s instructions. Full-length of
vegfaa165 (NM_131408.3) [26] PCR fragment was digested with
EcoRI in pGEM T-easy vector (Promega), and transferred into
expression vector pCS2+. Clones with sense orientation were
confirmed by sequencing. Generation of capped mRNA was
performed as described above. The vegfaa165, hif1a, and vhl
templates for ribo-probes were generated by PCR using the
following primers; vegfaa165: (forward) 59 GAGAGCCAGC-
GACTCACCGCAACAC 39, (reverse) 59 GTTCGCTCGAT-
CATCATCTTGGC 39, hif-1a: (forward) 59 TACT-
GAGTGGTTTCACCCAGG 39, (reverse) 59
CAGCTTCCTCTTACGCTGGAT 39, vhl : (forward) 59
GGATCCTCCTGTCTTTGACGATGCCC 39, (reverse) 59
GTTAATGTTGATGTTTTCGTCTG 39. To synthesize digox-
igenin (Roche)-labeled anti-sense RNA probes, plasmids contain-
ing fih-1, kdrl (NM_131472.1), fli1a (NM_131348.2), hif1a
(NM_200233.1), and vhl (NM_001080684.1) were linearized by
using restriction enzymes, respectively, prior to transcription with
either T3, SP6 or T7 RNA polymerase (Fermentas). To
preferentially detect vegfaa165 message, anti-sense RNA probe
was designed from the exon7 of the vegfaa gene.
Microinjection of mRNA and morpholino
oligonucleotides
fih-1 (100pg) or vegfaa165 mRNA (30pg or 120pg) were injected
into 1–4 cell stage embryos. To confirm the injected volume, each
injection solution was visualized by adding phenol red with final
concentration 0.5%. Also, 200pg of fih-1DC or 80pg of fih-1DN
was injected into Tg(kdrl:EGFP) 1–2 cell stage embryos. The
sequence of the anti-sense mopholino (Gene Tools) used to target
the exon 2 splice donor site of the fih-1gene was 59-CATTAAT-
CACACTGACATACCTTCC 239. The sequence of the control
MO was 59-CCTCTTACCTCAGTTACAATTTATA 239. Ap-
proximately 9 ng of fih-1 or control MOs was injected into 1–2
cell stage embryos. Rescue experiments were performed by
injecting 200 pg of fih-1 full-length mRNA into fih-1 MO-
injected embryos.
Cell cultures and transfection
COS7 cells (from ATCC) were maintained in DMEM medium
containing 10% heat inactivated fetal bovine serum and anti-
biotics. The cDNA coding for zebrafish fih-1 was subcloned into
pCS2+ EGFP via NcoI. fih-1 pCS2+ EGFP was co-transfected
with mouse HA-Mib1 pcDNA and/or HA-Hif1a pcDNA into the
cultured cells. Cells were transfected with appropriate amounts of
plasmid DNA using Lipofectamine Plus (Invitrogen).
Treatment of VEGF receptor tyrosine kinase inhibitor
with zebrafish embryo
5 mg/ml of VEGF receptor tyrosine kinase inhibitor
(VEGFRTKI, Calbiochem) was treated in fih-1 MO-injected
Tg(kdrl:EGFP) embryos from 55 hpf to 80 hpf. Control
Tg(kdrl:EGFP) embryos were treated in DMSO from 55 hpf to
80 hpf.
FIH-1 in Vascular Development
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Whole-mount in situ hybridization and
Immunohistochemistry
Whole mount in situ hybridization was performed as previously
reported [27]. For immunohistochemistry, COS7 cells were
transfected with various plasmids. At 24 hours post-transfection,
the cells were washed in PBS and fixed in 4% paraformaldehyde
for 30 min at 4 C. The fixed cells were incubated in blocking
solution (3% skim milk and 0.1% Triton X-100 in PBS) overnight
at 4 C, and then stained with appropriate primary antibody in 3%
skim milk in PBS for 1 h at room temperature. Subsequently, the
cells were incubated with an anti-mouse antibody conjugated with
Rhodamine for 30 min at room temperature. For DNA staining,
cells were stained with Hoechst 33342 for 5 min. After rinsing with
0.1% Triton X-100 in PBS, the cells were mounted on glass slides
and analyzed with a Leica DM5000B fluorescent microscope.
Figure 1. Association of Factor Inhibiting HIF-1a (FIH-1) with Mindbomb. (A) Amino acid sequence comparison between human and
zebrafish FIH-1/Fih-1. JmjC domain is marked as a red box. Region of FIH-1 which mediates its interaction with HIF-1a is marked as blue underline.
Red asterisks indicate metal coordination sites. (B) Zebrafish Fih-1 co-localizes with Mib1 in transiently transduced Cos7 cells. (C) Zebrafish Fih-1 co-
localizes with Hif1a in transiently transduced Cos7 cells. Expression vectors encoding HA-Mib1 and Fih-1-GFP (For B) or HA-Hif-1a and Fih-1-GFP (For
C) were used.
doi:10.1371/journal.pone.0109517.g001
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Microangiography
Microangiography was performed as previously reported [28].
FITC-Dextran with a molecular weight of 2000 kDa (Sigma) was
used for microangiography. FITC-Dextran was solubilized in
Danieau solution and this solution injected into the sinus venosa/
cardinal vein of the anaesthetized 48 h embryo.
Figure 2. Expression pattern of fih-1, vhl, and hif-1a. (A) RT-PCR analysis showing expression of fih-1, hif-1a, vhl, and b-actin during
development. (B) Whole-mount in situ hybridization of fih-1 during development. As early as 8 hpf, fih-1 expression can be detected. At 14 hpf, fih-1
is strongly expressed at the midbrain-hindbrain boundary and eye. At 25 hpf, expression of fih-1 is expanded to the optic vesicle and ventral
mesoderm. The expression of fih-1 in midbrain-hindbrain boundary, eye, optic vesicle and ventral mesoderm is maintained at later stages. (C)
Expression of hif1a, a known target of Fih-1, at 25 hpf and 36 hpf. (D) Expression of vhl, which is known to interact and synergize with Fih-1, at the
same developmental stage. Both hif1a and vhl express within the similar anatomical region as fih-1.
doi:10.1371/journal.pone.0109517.g002
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Figure 3. Fih-1 negatively modulates angiogenesis during development. (A) Validation of the morpholino (MO) targeting fih-1. Injection of
fih-1 MO interferes with mRNA splicing, leading to the retention of an intron and premature translation termination. (B) Gross morphology of fih-1
MO-injected embryos in comparison with control MO-injected embryos. No obvious gross morphological defects were observed at 55 hpf. (C) At
50 hpf, injection of fih-1 MO did not cause any obvious increase in angiogenic sprouts, however, exuberant angiogenic sprouts emerge from the
intersegmental vessels (ISVs) in fih-1 MO-injected embryos at 80 and 122 hpf. (D) Concomitant injection of fih-1 mRNA can rescue exuberant
angiogenesis caused by fih-1 MO-injected embryos. On the right column, control (top, n = 12), fih-1 MO (middle, n = 20), or fih-1 MO and fih-1 mRNA
(bottom, n= 20) injected embryos. Arrows point to ectopic angiogenic sprouts. Quantification of ectopic angiogenic sprouts per embryo is shown on
the right. Asterisk notes statistical significance in the number of ISVs between fih-1 MO and fih-1 MO and fih-1 mRNA injected embryos. Error bars are
standard deviation.
doi:10.1371/journal.pone.0109517.g003
Figure 4. Fih-1 negatively regulates Vegf-aa165 in zebrafish embryos. (A) At 28 hpf, both fih-1 and vegf-aa165 transcript are selectively
expressed within the anterior somites and ventral mesoderm. (B) Attenuation of Fih-1 activity in zebrafish elevates the level of vegf-aa165 expression
at 50 hpf. Arrowheads point to vegf-aa165 expression in somites caused by lack of Fih-1 activity. Similarly, the level of vegfaa transcript in 48 hpf
control or fih-1 MO-injected embryos was evaluated by quantitative RT-PCR. Error bars are standard deviation (right). (C) Ectopic expression of Fih-1
decreases the level of vegf-aa165 expression in a dose-dependent manner at 28 hpf. (D) Functional relationship between Fih-1 and Vegf-aa165. Ectopic
expression of Vegf-aa165 under the regulation of hsp70l promoter caused a similar vascular phenotype as observed in fih-1 MO-injected embryos.
Moreover, inhibition of Vegf-A signaling can drastically reduce the exuberant angiogenic sprouts in fih-1 MO-injected embryos at 80 hpf. Arrows
point to ectopic sprouts.
doi:10.1371/journal.pone.0109517.g004
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Generation of Tg(hsp70l:vegfaa165)ck4 transgenic
zebrafish
A 1.5 kb heat-shock 70 promoter cloned into vegfaa165 pCS2+.
The plasmid was linearized by SacII and microinjected into
Tg(kdrl:EGFP) embryos of 1–2 cell stage. Embryos were
maintained in egg water and screened for germ-line transmitted
founders by whole-mount in situ hybridization with vegfaa165
ribo-probe. Transgene positive f1 lines were identified by whole-
mount in situ hybridization with vegfaa165 and used to establish
the Tg(hsp70l:vegfaa165)ck4 line.
Heat-shock treatment of Tg(hsp70l:vegfaa165)ck4
Wild-type and heterozygous double Tg(hsp70l:vegfaa165)ck4
embryos at 50 hpf were collected and heat-shocked by placing in a
37uC incubator for 1 hour and then observed under the
fluorescence microscope at 80 hpf (Leica, DM5000B).
Quantitative Real-time PCR
Control and fih-1 MOs were injected at 1–2 cell stage, and
resulting embryos were collected at 48 hpf to extract total RNA
using RNeasy Mini Kit (Qiagen). 1 mg total RNA was used to
generate cDNA using High-Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems). Quantitative real-time reaction was
performed using Fast SYBR Green Master Mix Real-Time PCR
Figure 5. Over-expression of Fih-1 inhibits the formation of angiogenic vessels during development. (A) Whole-mount in situ
hybridization with fli1a and kdrl in control or fih-1 mRNA-injected embryos. In fih-1 mRNA-injected embryos, the number of intersegmental vessels
(black arrowheads) was substantially reduced. (B) Microangiography of fih-1 mRNA-injected embryos shows a lack of circulation in intersegmental
vessels. (C) Ectopic expression of vegf-aa165 restored impaired angiogenic vessel formation in fih-1 mRNA-injected embryos at 52 hpf. Arrowheads
point to intersegmental vessels which fail to anastomose at the dorsal-most part of the embryos. (D) Schematic diagram of two constructs that
encode either N-terminus or C-terminus deleted Fih-1. Both N-terminus only Fih-1 (Fih-1DC) and C-terminus only Fih-1 (Fih-1DN) contain JmjC
domain and metal binding sites which are essential for hydroxylation of HIF-1a. (E) C-terminus of Fih-1 is essential for its anti-angiogenic activity.
While full length fih-1 or fih-1DN mRNA-injected embryos inhibit angiogenic sprouts of intersegmental vessels, fih-1DC mRNA-injected embryos at
72 hpf do not show any obvious vascular defects. Arrowheads point to angiogenic sprouts which fail to extend to the dorsal-most side of the
embryos.
doi:10.1371/journal.pone.0109517.g005
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Master Mix (Applied Biosystems). Following primers were used:
vegfaa forward primer, 59-TGCTGGTAGACATCATCCA-39;
vegfaa reverse primer, 59-TTATGCTGCGATACGCGTT-39;
gapdh forward primer, 59-AGCACTGTTCATGCCATCA-39;
gapdh reverse primer, 59-GTCAGATCCACAACAGAGA-39.
BrdU (5-bromo-2-deoxyuridine) incorperation and whole-
mount immunostaining
Dechorionated embryos were incubated at 28.5uC in 10 mM
BrdU (Sigma)/15% Dimethylsulfoxide (DMSO) for 20 minutes.
After incubation, embryos were fixed for 2 hours at room
temperature in 4% paraformaldehyde. Embryos were washed
four times by PBS with 0.1% tween 20 (PBST) for 5 minutes and
incubated in 10 mg/ml proteinase K (Roche) for 10 minutes.
Embryos were re-fixed in 4% paraformaldehyde for 20 minutes
and washed with H2O, then incubated in 2N HCL for 1 hour.
Then, embryos were blocked in 5% horse serum for 1 hour. Next,
embryos were incubated with anti-BrdU antibody (Sigma, 1:1000)
in for 2 hours at room temperature. Subsequently, embryos were
incubated for overnight at 4uC with Rhodamine-conjugated anti-
mouse secondary antibody (Molecular Probe, 1:500), and washed
with PBST. Photographs were taken on a Zeiss LSM5.
Results
FIH-1 physically associates with Mindbomb
To identify interactors of Mib1, we performed yeast two-hybrid
screens using the Ankyrin repeats of Mib1 (Fig. 1A and Fig. S1).
From a screening of 1.446106 colonies of cDNA library, we have
isolated a number of candidates that physically interact with Mib1
(Fig. 1B), including SNX5 [29], RanBP9, and MAP1A. In
addition, FIH-1, also known as HIF1AN, a protein that negatively
modulates HIF-1a activity [20,23] was also identified as a
potential interactor of Mib1.
FIH-1 appears to be a highly conserved protein; human and
zebrafish FIH-1 are 91 percent similar and 79 percent identical.
Specifically, amino acid 133 to 301 which roughly corresponds to
the Jumanji (JmjC) domain, has over 96 percent homology,
illustrating the importance of this domain for FIH-1 function
(Fig. 1C, red box). Previously, FIH-1 has shown to associate with
Mib and its paralog Mib2, and undergoes Mib/Mib2-mediated
Ubiquitination [21]. Consistent with this report, we find that FIH-
1 and Mib1 appear to colocalize in the perinuclear region in
cultured cells which were transfected with FIH-1-GFP and HA-
Mib1 (Fig. 1B). In addition, FIH-1 appears to colocalize with HIF-
1a while FIH-1 is also known to interact with HIF-1a (Fig. 1C)
[20].
During development, expression of fih-1/hif1an can be detected
as early as the 4-cell stage, suggesting that fih-1 may be maternally
deposited (Fig. 2A). Its expression subsequently decreases until
24 hours post-fertilization (hpf), which is reminiscent of vhl
expression, another well-characterized inhibitor of HIF-1a
[30,31]. While fih-1 is widely expressed in developing embryos,
its expression is gradually restricted to the ventral mesoderm,
midbrain hindbrain boundary, and eye at later stages (Fig. 2B).
The expression pattern of fih-1 at later stages (25 and 36 hpf) is
comparable to those of vhl and hif1a (Fig. 2C and 2D), further
illustrating the functional relationship between FIH-1, VHL, and
HIF-1 during development (Fig. 2A).
Inhibition of FIH-1 leads to increased angiogenic activity
in zebrafish embryos
Considering its proposed role as a negative modulator of
HIF-1a signaling [20], FIH-1 may regulate vascular develop-
ment. To examine this possibility, we first injected a morpholino
(MO) targeting fih-1 into developing zebrafish embryos
(Fig. 3A). At 12 hpf, inhibition of fih-1 did not cause any
discernible changes in the expression of early EC makers, such
as fli-1a and scl (Fig. S2). At 55 hpf, fih-1 MO-injected
embryos were morphologically comparable to control MO-
injected embryos (Fig. 3B). To better elucidate the function of
FIH-1 during vascular development, we examined the mor-
phology of the developing vascular structure in Tg(kdrl:EGFP)
transgenic zebrafish [24]. At 50 hpf, when the initial sprouting
of ISVs from the dorsal aorta has been completed, we did not
observe any obvious difference between control and fih-1 MO-
injected embryos. However, at this time point, proliferation rate
of endothelial cells in fih-1 MO-injected embryos had been
substantially increased, suggesting that Vegf-A signaling may be
up-regulated (Fig. S3). Subsequently, approximately 80 and
122 hpf, ectopic secondary sprouts become emanate from the
ISVs in fih-1 MO-injected embryos (Fig. 3C, red arrows). The
exuberant secondary sprouts appear to be caused by a reduced
level of FIH-1 activity since co-injection of fih-1 mRNA is able
to rescue this phenotype (Fig. 3D).
FIH-1 negatively regulates VEGF-A165 in a HIF-1a-
dependent manner
Since FIH-1 negatively regulates HIF-1a, which in turn
activates VEGF-A activity [20,23], it is possible that the phenotype
caused by the lack of FIH-1 activity may increase the transcription
of vegfa. An elevated level of previously identified transcriptional
targets of HIF-1a such as hmox1a [32] and glut3 [33] in fih-1
MO-injected embryos also supports this notion (Fig. S4). To
examine whether the phenotype caused by the lack of FIH-1
activity (e.g. ectopic ISVs) may be induced by an elevated level of
VEGF-A signaling, we examined the expression of vegf-aa165.
Consistent with this idea, we find that vegf-aa165, a transcript
encoding the predominant VEGF-A isoform, and fih-1 express in
a complementary manner in wild-type embryos at 28 hpf
(Fig. 4A). In addition, the expression level of vegf-aa165 is
substantially elevated in fih-1 MO-injected embryos (Fig. 4B),
while drastically reduced in fih-1 mRNA-injected embryos
(Fig. 4C). Therefore, it appears that the expression level of vegf-
aa165 appears to be negatively regulated by FIH-1 during vascular
development.
To further elucidate the functional relationship between VEGF-
A165 and FIH-1, we generated a transgenic zebrafish line that
expresses vegf-aa165 under the regulation of a hsp70l promoter,
Tg(hspl:vegfaa165)ck4 (Fig. S5). The ectopic expression of vegf-
aa165 was induced at 50 hpf, and the resulting vascular phenotype
was analyzed at 80 hpf. All vegf-aa165 over-expressing embryos
possess ectopic ISVs, similar to vascular defects in fih-1 MO-
injected embryos (Fig. 4D, red arrows). Conversely, treating fih-1
MO-injected embryos with VEGF receptor tyrosine kinase
inhibitor (VEGFTKI, Calbiochem), a small chemical antagonist
of VEGF-A signaling, drastically reduces the ectopic ISVs
(Fig. 4D). Taken together, our data suggest that FIH-1 may
modulate vascular development by regulating VEGF-A165
activity via HIF-1a.
Augmented FIH-1 activity suppresses angiogenesis in
zebrafish embryos
Our data suggest that FIH-1 is a negative regulator of VEGF-
A165 activity during development. In this scenario, the level of
FIH-1 and VEGF-A165 activity will be inversely proportional. To
examine whether an elevated level of FIH-1 can attenuate VEGF-
FIH-1 in Vascular Development
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A165 -mediated angiogenesis, we next expressed fih-1 mRNA in
wild-type embryos. In fih-1 mRNA-injected embryos, the
endothelial identity does not appear to be compromised (Fig. 5A).
However, we find that a significant fraction of fih-1 mRNA-
injected embryos failed to develop intersegmental vessels (ISVs),
whose formation is directly regulated by VEGF-A signaling
(Fig. 5A). Microangiography also indicates a lack of circulation
within ISVs in embryos injected with fih-1 mRNA (Fig. 5B),
further indicating the function of FIH-1 as a negative modulator
for vascular development in zebrafish embryos. Co-injection of
vegf-aa165 mRNA was able to rescue angiogenic defects in the
ISVs caused by fih-1 mRNA-injection (Fig. 5C), substantiating the
idea that balance between FIH-1 and VEGF-A165 activity is
essential to modulate vascular development in zebrafish embryos.
Taken together, our data suggest that FIH-1 negatively regulates
VEGF-A signaling via HIF-1a.
Previously, it has been reported that FIH-1 can directly bind to
VHL and HIF-1a via distinct domains, and form a ternary
complex [20]. Therefore, identifying the essential domains for
anti-angiogenic activity of FIH-1 in vivo may provide additional
information on how FIH-1 and HIF-1a interact. We generated
two truncated FIH-1 constructs, which lack either the C-terminus
(FIH-1DC) or N-terminus (FIH-1DN) of FIH-1 (Fig. 5D). As
shown previously in Fig. 5C, injection of full length FIH-1 severely
disrupted the formation of ISVs (Fig. 5E). Injection of FIH-1DN
construct led to similar vascular defects, while FIH-1DC failed to
cause a similar phenotype (Fig. 5E). Therefore, it appears that the
C-terminus is essential for the anti-angiogenic effects of FIH-1.
Considering that the C-terminus of FIH-1 contains essential
domains for its interaction with HIF-1a, our data indicate that
anti-angiogenic effects of FIH-1 may be mediated by its interaction
with HIF-1a during development.
Discussion
In this report, we show that FIH-1 physically interacts with Mib,
and functions as an anti-angiogenic factor by attenuating HIF-1a
and VEGF-A signaling. Inhibition of FIH-1 in zebrafish embryos
leads to ectopic angiogenesis from the ISVs, while over-expression
of FIH-1 attenuates formation of ISVs, indicating that FIH-1
functions as an anti-angiogenic cue during development. Interest-
ingly, global deletion of Fih-1 in mouse does not cause any obvious
vascular defects, but causes an elevated level of metabolism [34].
We believe different expression patterns of fih-1 and vhl in
zebrafish and mouse embryos can provide a potential explanation
for this seemingly perplexing discrepancy. In zebrafish embryos,
both fih-1 and vhl expression can be strongly detected at the 4-cell
stage, hinting that these transcripts are maternally deposited.
Moreover, zygotic expression of fih-1 precedes vhl and fih-1
expression appears to be more abundant. Consistently, MO-
mediated knock down of hif1an and vhl leads to similar vascular
defects [35]. In contrast, mouse fih-1 starts to express at E12.5
[34], two days later than the initiation of vhl expression [36]. We
find that the onset of phenotypic defects in fih-1 over-expressing
embryos appear to be earlier than in fih-1 MO-injected embryos.
Since we utilized splicing MO to attenuate the translation of fih-1
mRNA, it is possible that maternally deposited fih-1 mRNA may
undergo translation and ameliorate the knock-down phenotype.
Alternatively, FIH-1 may have yet unidentified targets which may
influence vascular development.
Previously, Notch signaling has been implicated as the main
effector of Mib function during vascular development since Mib
regulates endocytosis of Delta, a ligand for Notch [15]. As
previously reported [12], we found that mib2/2 embryos have
ectopic vessels potentially due to excessive angiogenesis. Interest-
ingly, vegfaa expression was unaltered in these embryos (Fig. S6),
suggesting that inhibition of Notch signaling may modulate the
angiogenic response independently to Vegf-Aa expression.
Considering the nature of FIH-1, it is tantalizing to postulate
that Mib and FIH-1 mutually serve as a substrate for each other’s
enzymatic activity, which creates a double negative feedback loop.
By hydroxylating Mib, FIH-1 may promote degradation of Mib
and inhibit Notch signaling, therefore promoting angiogenesis. In
turn, active FIH-1 can facilitate degradation of HIF-1a, and
attenuate the level of VEGF-A signaling, which negatively impacts
angiogenesis. However, in fih-1 MO-injected embryos, expression
of grl and dll4, known targets of Notch signaling, appears to be
unaltered (Figure S7), suggesting that FIH-1 may regulate HIF-1a
to regulate the Vegf-Aa expression, but is unlikely to influence the
expression of canonical Notch targets Further analyses on the
interaction between FIH-1 and Mib would address the functional
consequence of the their association in vascular development.
Taken together, our data suggest that FIH-1 may function as an
anti-angiogenic factor during vascular development by modulating
VEGF-A signaling. Considering that the developmental function
of anti-angiogenic factors are relatively unknown, our analyses on
FIH-1 may provide novel insight on vascular development.
Moreover, we find FIH-1 is physically associated with Mib, a
known regulator of Notch signaling.
Supporting Information
Figure S1 Schematic diagram of yeast two-hybrid
screen. (A) Schematic diagram of the Mindbomb1 structure.
Ankyrin repeats (AA410–744) from Mib protein was used as bait
for yeast two hybrid screen. (B) List of potential interactors of Mib
identified from the yeast two hybrid screen. (C) Strategy for yeast
two hybrid screen.
(TIF)
Figure S2 Specification of endothelial cells is not
affected in fih-1 MO-injected embryos. Micrographs of
whole-mount in situ hybridization with fli-1a (top rorw) and scl
(bottom row) in control (left column) or fih-1 (right column) MO-
injected embryos at 12 hpf.
(TIF)
Figure S3 Fih-1 regulates endothelial cell proliferation.
Proliferating endothelial cells in control (A and C) or fih-1 MO-
injected (B and D) at 55 hpf (A and B) and 72 hpf (C and D). The
number of BrdU positive endothelial cells within the intersegmen-
tal vessels (ISVs) was significantly increased in fih-1 MO-injected
embryos at 55 and 72 hpf, compared to control embryos. Arrows
indicate GFP+/BrdU+ endothelial cells in Tg(kdrl:EGFP) trans-
genic zebrafish (B’’ and D’’). Quantification on the number of
GFP+/BrdU+ endothelial cells are shown in E. Asterisks indicate
statistical significance (* p,0.005). Error bars, 6SD. n= 6 (55 hpf
control), 5 (72 hpf control), 8 (55 hpf fih-1 MO-injected), and 9
(72 hpf fih-1 MO-injected).
(TIF)
Figure S4 fih-1 regulates hif-1a targets during zebrafish
development. (A) Schematic diagram on negative regulation of
Hif-1a by Fih-1. Whole-mount in situ hybridization of heme
oygenase1a (hmox1a) (B) and glucose transporter-3 (glut3) (C) in
control or fih-1 MO-injected embryos. Lack of Fih-1 strongly
induces expression of known Hif-1a targets.
(TIF)
Figure S5 Generation of Tg(hsp70l:vegfaa165)ck4. (A)
Schematic diagram of the construct used to generate the
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Tg(hsp70l:vegfaa165) ck4 zebrafish line. 12 hpf Tg(hsp70l:veg-
faa165) ck4 embryos without heat-shock (B) or with heat-shock
(C). Strong induction of vegfaa165 can be detected upon heat-
shock treatment.
(TIF)
Figure S6 vegfaa expression was not altered in mib2/2
embryos. (A and B) Expression of vegfaa was evaluated by whole
mount in situ hybridization at 25 hpf in wild-type and mib2/2
embryos.
(TIF)
Figure S7 Endothelial notch target genes were not
changed in fih-1 MO-injected embryos. (A–D) Expression
of gridlock (grl) and delta lik-4 (dll4) were evaluated by whole
mount in situ hybridization at 25 hpf in control and fih-1 MO-
injected embryos.
(TIF)
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